Abstract
COVID-19 is quickly spreading around the world and carries along with it a significant threat to public health. This study sought to apply meta-analysis to more precisely and accurately estimate the basic reproduction number (R0) of COVID-19 in order to evaluate the effectiveness of the isolation policy across countries, and the corresponding public health capability to care for patients. Prior estimates of R0 have varied widely and range from 1.95 to 6.49. Utilizing meta-analysis techniques we determined a more robust estimation of 3.05 for R0, which is substantially larger than that provided by the WHO. We also present the infectious rate standardized to per million population, which has proved to be a good index to determine whether the isolation measures in specific countries are effective. Also, this standardized infection rate can be used to determine whether the current infectious severity status is out of range of the national health capacity. Finally, we utilize our robust estimate of R0 and the standardized infectious rate to illustrate that the early and aggressive isolation measures enforced by the Chinese government were substantially more effective in controlling the negative impact COVID-19 than the more permissive measures enacted early in Italy and the United States.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
https://www.unmc.edu/publichealth/departments/biostatistics/facultyandstaff/jianghu-dong.html
